Part B Drug Transition Period
Customize your policy alerts
Sign up for globalhealth Policy GH-RX-083 alerts
Get alerted when Policy GH-RX-083 changes without checking for updates manually.
Monitor payer policy activity
Policy governing a minimum 90-day transition period for Medicare Advantage (MA) plan enrollees receiving active courses of treatment that include physician-administered Part B drugs; applies to GlobalHealth Holdings, LLC and GlobalHealth, Inc.
Updated the Organization Determination definition and added definitions for Active Course of Treatment, Course of Treatment, Prior Authorization, Reliable Evidence, Similar Fault, and MR4; replaced mention of Healthaxis with MR4; added section on the effect of prior authorization to align with CMS-4208-F.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.